Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Christoph Losem, Michael Koenigsmann & Christine Rudolph. (2017) Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study. OncoTargets and Therapy 10, pages 1295-1305.
Read now
Read now
Jean-Emmanuel Kurtz, Pierre Soubeyran, Mauricette Michallet, Elisabeth Luporsi & Hélène Albrand. (2016) Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients. OncoTargets and Therapy 9, pages 6689-6693.
Read now
Read now
Theodor Dingermann & Florian Scotte. (2016) Biosimilar epoetin zeta: extrapolation of indications and real world utilization experience. Expert Opinion on Biological Therapy 16:7, pages 967-974.
Read now
Read now
Massimo Martino, Francesco Lanza, Taner Demirer, Tiziana Moscato, Simona Secondino & Paolo Pedrazzoli. (2015) Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 15:2, pages 195-211.
Read now
Read now
Alaa Bagalagel, Abdulaziz Mohammed, Karen MacDonald & Ivo Abraham. (2013) Clinical efficacy and safety of SB309, a biosimilar recombinant human erythropoietin, in the management of anemia. Biosimilars 3, pages 35-43.
Read now
Read now
Ivo Abraham & Karen MacDonald. (2012) Clinical safety of biosimilar recombinant human erythropoietins. Expert Opinion on Drug Safety 11:5, pages 819-840.
Read now
Read now
Wolfgang Jelkmann. (2012) Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments. Expert Opinion on Biological Therapy 12:5, pages 581-592.
Read now
Read now
Articles from other publishers (11)
Marc Benderitter, Eduardo Herrera-Reyes, Yvan Gigov, Bertrand Souleau, Christelle Huet, François Trompier, Thierry Fagot, Eric Grégoire, Jean Valère Malfuson, Johanna Konopacki-Potet, Elena Buglova, Jean-Jacques Lataillade, Radia Tamarat, Patrick Gourmelon & Thierry de Revel. (2021) Hematopoietic Recovery using Multi-Cytokine Therapy in 8 Patients Presenting Radiation-Induced Myelosuppression after Radiological Accidents. Radiation Research 196:6.
Crossref
Crossref
Constantinos E. Alifieris, Kyriakos Orfanakos, Aristina Papanota, George P. Stathopoulos, Nikolaos Sitaras & Dimitrios T. Trafalis. (2017) A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors. Journal of Cancer Research and Clinical Oncology 143:4, pages 717-725.
Crossref
Crossref
Amit B. Agarwal & Ali McBride. (2016) Understanding the biosimilar approval and extrapolation process—A case study of an epoetin biosimilar. Critical Reviews in Oncology/Hematology 104, pages 98-107.
Crossref
Crossref
Pere Gascon. (2015) The evolving role of biosimilars in haematology–oncology: a practical perspective. Therapeutic Advances in Hematology 6:6, pages 267-281.
Crossref
Crossref
A. Tiotiu, C. Clément-Duchêne & Y. Martinet. (2015) Prise en charge de l’anémie chimio-induite dans le cancer bronchique. Revue des Maladies Respiratoires 32:8, pages 809-821.
Crossref
Crossref
Mauricette Michallet, Elisabeth Luporsi, Pierre Soubeyran, Nadia Ali Amar, Vincent Boulanger, Miguel Carreiro, Louis-Marie Dourthe, Jean-Luc Labourey, Daniel Lepille, Frédéric Maloisel, Jean-Loup Mouysset, Sophie Nahon, Bérengère Narciso, Pierre Nouyrigat, Raouf Radji, Nacéra Sakek & Hélène Albrand. (2014) BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study. BMC Cancer 14:1.
Crossref
Crossref
Nataša Debeljak, Peter Solár & Arthur J. Sytkowski. (2014) Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction. Frontiers in Immunology 5.
Crossref
Crossref
Carol A. Forbes, Gillian Worthy, Julie Harker, Jos Kleijnen, Lucie Kutikova, Laurent Zelek & Simon Van Belle. (2014) Dose Efficiency of Erythropoiesis-Stimulating Agents for the Treatment of Patients With Chemotherapy-Induced Anemia: A Systematic Review. Clinical Therapeutics 36:4, pages 594-610.e4.
Crossref
Crossref
Luca MalcovatiEva Hellström-LindbergDavid BowenLionel AdèsJaroslav CermakConsuelo del CañizoMatteo G. Della Porta, Pierre FenauxNorbert GattermannUlrich GermingJoop H. JansenMoshe MittelmanGhulam MuftiUwe PlatzbeckerGuillermo F. SanzDominik SelleslagMette Skov-HolmReinhard StauderArgiris Symeonidis, Arjan A. van de Loosdrecht, Theo de WitteMario Cazzola. (2013) Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 122:17, pages 2943-2964.
Crossref
Crossref
Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert & Julia Bohlius. (2012) Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Cornelius F. Waller. (2012) Biosimilars and their use in hematology and oncology. Community Oncology 9:6, pages 198-205.
Crossref
Crossref